APA

Bidstrup T. B., Bjørnsdottir I., Sidelmann U. G., Thomsen M. S. & Hansen K. T. (20040206). CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. : British journal of clinical pharmacology.

Chicago

Bidstrup Tanja Busk, Bjørnsdottir Inga, Sidelmann Ulla Grove, Thomsen Mikael Søndergård and Hansen Kristian Tage. 20040206. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. : British journal of clinical pharmacology.

Harvard

Bidstrup T. B., Bjørnsdottir I., Sidelmann U. G., Thomsen M. S. and Hansen K. T. (20040206). CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. : British journal of clinical pharmacology.

MLA

Bidstrup Tanja Busk, Bjørnsdottir Inga, Sidelmann Ulla Grove, Thomsen Mikael Søndergård and Hansen Kristian Tage. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. : British journal of clinical pharmacology. 20040206.